Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
International Journal of Molecular Sciences|January 11, 2024
Altered Serum Alpha1-Antitrypsin Protease Inhibition before and after Clinical Hematopoietic Stem Cell Transplantation: Association with Risk for Non-Relapse MortalityIdo Brami, Tsila Zuckerman, Ron Ram, et al.
Frontiers in Immunology|May 27, 2025
MIF functional polymorphisms are associated with acute GVHD progression and steroid-refractorinessAviran Aharon, Batia Avni, Daniel Louzoun, et al.
Annals of Hematology|October 10, 2021
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective studyOren Pasvolsky, Shai Shimony, Ron Ram, et al.
Cancers|October 26, 2024
The Impact of FDA-Approved Novel Agents for Steroid-Refractory Chronic Graft vs. Host Disease on Treatment Patterns and Outcomes-A Single-Center Longitudinal Cohort AnalysisGil Fridberg, Odelia Amit, Chen Karni, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2015
Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II StudyMoshe Yeshurun, Ofer Shpilberg, Corina Herscovici, et al.
Bone Marrow Transplantation|November 24, 2020
Anti-CD19 CAR-T therapy for EBV-negative posttransplantation lymphoproliferative disease-a single center case seriesEfrat Luttwak, David Hagin, Chava Perry, et al.
Blood Advances|August 14, 2020
Efficacy of folinic acid rescue following MTX GVHD prophylaxis: results of a double-blind, randomized, controlled studyMoshe Yeshurun, Uri Rozovski, Oren Pasvolsky, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2021
[18F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studiesDan Cohen, Efrat Luttwak, Ofrat Beyar-Katz, et al.
Vaccines|April 28, 2023
Third BNT162b2 mRNA SARS-CoV-2 Vaccine Dose Significantly Enhances Immunogenicity in Recipients of Allogeneic Hematopoietic Stem Cell TransplantationIsrael Henig, Jonathan Isenberg, Dana Yehudai-Ofir, et al.
Respiratory Medicine|June 13, 2025
Bronchiectasis after allogeneic hematopoietic cell transplantation - an underdiagnosed complicationOphir Freund, Yitzhac Hadad, Anne Bergeron, et al.
Pageof 13